Matches in Nanopublications for { ?s ?p "[Most importantly, the translation of the described results to human primary samples demonstrated that patients with prostate or breast tumors with low levels of KLF2 and high expression of EZH2 had a shorter overall survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP244609.RAeCnbxnQJSyHgWeRwAuONmgmTZndsE7r5x2hIK9rIDcM130_assertion description "[Most importantly, the translation of the described results to human primary samples demonstrated that patients with prostate or breast tumors with low levels of KLF2 and high expression of EZH2 had a shorter overall survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP244609.RAeCnbxnQJSyHgWeRwAuONmgmTZndsE7r5x2hIK9rIDcM130_provenance.
- NP722026.RAlPWemKW1shcmshXuLUxLbBjXq6ss5LLfBZ8K5FrKf0E130_assertion description "[Most importantly, the translation of the described results to human primary samples demonstrated that patients with prostate or breast tumors with low levels of KLF2 and high expression of EZH2 had a shorter overall survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP722026.RAlPWemKW1shcmshXuLUxLbBjXq6ss5LLfBZ8K5FrKf0E130_provenance.
- NP389168.RABE-paUpQyZyCSI24sg5JEahzxzubfH2IQHEzXLpj1Lc130_assertion description "[Most importantly, the translation of the described results to human primary samples demonstrated that patients with prostate or breast tumors with low levels of KLF2 and high expression of EZH2 had a shorter overall survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP389168.RABE-paUpQyZyCSI24sg5JEahzxzubfH2IQHEzXLpj1Lc130_provenance.
- NP841287.RAVH0W0uZD-u2ouNCnCaxFNceMRQCVTXxMr4ApbiBrMy4130_assertion description "[Most importantly, the translation of the described results to human primary samples demonstrated that patients with prostate or breast tumors with low levels of KLF2 and high expression of EZH2 had a shorter overall survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP841287.RAVH0W0uZD-u2ouNCnCaxFNceMRQCVTXxMr4ApbiBrMy4130_provenance.
- assertion description "[Most importantly, the translation of the described results to human primary samples demonstrated that patients with prostate or breast tumors with low levels of KLF2 and high expression of EZH2 had a shorter overall survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Most importantly, the translation of the described results to human primary samples demonstrated that patients with prostate or breast tumors with low levels of KLF2 and high expression of EZH2 had a shorter overall survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP921453.RAMwFgLys7E4ZioopDvRri9G-Wv2MYvY-0z5qY0P6in8A130_assertion description "[Most importantly, the translation of the described results to human primary samples demonstrated that patients with prostate or breast tumors with low levels of KLF2 and high expression of EZH2 had a shorter overall survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP921453.RAMwFgLys7E4ZioopDvRri9G-Wv2MYvY-0z5qY0P6in8A130_provenance.
- NP921454.RAJ-fI5NcfjwfErrsjTyt0ozg3x4hoepw1Hl_IT0wIrfg130_assertion description "[Most importantly, the translation of the described results to human primary samples demonstrated that patients with prostate or breast tumors with low levels of KLF2 and high expression of EZH2 had a shorter overall survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP921454.RAJ-fI5NcfjwfErrsjTyt0ozg3x4hoepw1Hl_IT0wIrfg130_provenance.